Opko Health, Inc. (OPK): Price and Financial Metrics

Opko Health, Inc. (OPK)

Today's Latest Price: $3.83 USD

0.07 (1.86%)

Updated Jul 7 6:55pm

Add OPK to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 336 in Biotech

See all "A" rated Strong Buy stocks

OPK Stock Summary

  • OPK's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 21.52% of US stocks.
  • With a year-over-year growth in debt of -23.73%, Opko Health Inc's debt growth rate surpasses merely 12.09% of about US stocks.
  • As for revenue growth, note that OPK's revenue has grown -6.98% over the past 12 months; that beats the revenue growth of only 23.95% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Opko Health Inc are LIVN, SPCB, EVOL, HSTM, and AGCO.
  • OPK's SEC filings can be seen here. And to visit Opko Health Inc's official web site, go to www.opko.com.
OPK Daily Price Range
OPK 52-Week Price Range

OPK Stock Price Chart Technical Analysis Charts

OPK Price/Volume Stats

Current price $3.83 52-week high $4.04
Prev. close $3.76 52-week low $1.12
Day low $3.67 Volume 10,769,100
Day high $3.85 Avg. volume 13,489,146
50-day MA $2.57 Dividend yield N/A
200-day MA $1.87 Market Cap 2.57B

Opko Health, Inc. (OPK) Company Bio

Opko Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies. The company was founded in 2005 and is based in Miami, Florida.

OPK Latest News Stream

Event/TimeNews Detail
Loading, please wait...

OPK Latest Social Stream

Loading social stream, please wait...

View Full OPK Social Stream

Latest OPK News From Around the Web

Below are the latest news stories about Opko Health Inc that investors may wish to consider to help them evaluate OPK as an investment opportunity.

Here's Why You Should Invest in OPKO Health (OPK) Stock Now

OPKO Health (OPK) continues to benefit from lucrative prospects in RAYALDEE and BioReference platforms.

Yahoo | July 6, 2020

Is OPKO Health (OPK) Outperforming Other Medical Stocks This Year?

Is (OPK) Outperforming Other Medical Stocks This Year?

Yahoo | July 3, 2020

The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1) AbbVie Inc (NYSE: ABBV ) ADC Therapeutics SA (NYSE: ADCT ) Affimed NV (NASDAQ: AFMD ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Akero Therapeutics Inc (NASDAQ: AKRO ) ( announced positive results for mid-stage study of NASH drug) Amgen, Inc. (NASDAQ: AMGN ) (reacted to a favorable court ruling on its Enbrel patent litigation) Aptinyx Inc (NASDAQ: APTX ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP ) Crispr Therapeutics AG (NASDAQ: CRSP ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Hologic, Inc. (NASDAQ: HOLX ) Legend Biotech Corp (NASDAQ: LEGN ) Liminal BioSciences Inc (NASDAQ: LMNL ) (announce...

Benzinga | July 2, 2020

Buy Opko Stock For Two Ways to Play the Ongoing Pandemic

Like the rest of us, Wall Street is obsessed with the novel coronavirus. Seemingly every company has some sort of Covid-19 angle, from creating personal protective gear, manufacturing medical equipment, creating or running tests and working on a vaccine. Those that have a successful angle are richly rewarded. That's where we are lately with Opko Health (NASDAQ:OPK) stock.Source: Shutterstock.com Opko, a midsize Miami-based company with a market cap of just over $2 billion, is up more than 130% so far this year. And while shares are still less than $4, the company is now trading at levels unseen since January 2019.What's driving OPK stock higher? It's Covid-19, of course? This company has two ways to play the pandemic.InvestorPlace - Stock Market News, Stock Advice & Trading ...

Yahoo | July 2, 2020

The Daily Biotech Pulse: T2 Biosystems Launches COVID-19 Test, Akero Aces Midstage NASH Study, Aravive Added to Russell Indexes

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) ADC Therapeutics SA (NYSE: ADCT ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Alterity Therapeutics Ltd (NASDAQ: ATHE ) ( announced agreement with the FDA regarding Phase 2 study of Parkinsonian disorder drug) Calliditas Therapeutics AB ADR (NASDAQ: CALT ) GENMAB A/S/S ADR (NASDAQ: GMAB ) - partner Seattle Genetics, Inc. (NASDAQ: SGEN ) announced positive results for antibody-drug conjugate for cervical cancer Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Hologic, Inc. (NASDAQ: HOLX ) ( reacted to a positive analyst action) Legend Biotech Corp (NASDAQ: LEGN ) Meridian Bioscience, Inc. (NASDAQ: VIVO ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Novavax...

Benzinga | July 1, 2020

Read More 'OPK' Stories Here

OPK Price Returns

1-mo 41.85%
3-mo 167.83%
6-mo 164.14%
1-year 68.72%
3-year -39.97%
5-year -76.86%
YTD 160.54%
2019 -51.16%
2018 -38.57%
2017 -47.31%
2016 -7.46%
2015 0.60%

Continue Researching OPK

Want to see what other sources are saying about Opko Health Inc's financials and stock price? Try the links below:

Opko Health Inc (OPK) Stock Price | Nasdaq
Opko Health Inc (OPK) Stock Quote, History and News - Yahoo Finance
Opko Health Inc (OPK) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.0017 seconds.